Mohammed Abdul Waduud1,2, Penelope Poppy Janpen Sucharitkul1, Michael Drozd2, Ankit Gupta1, Christopher Hammond3, David Julian Ashbridge Scott1,2. 1. The Leeds Vascular Institute, Leeds General Infirmary, Leeds Teaching Hospital NHS Trust, Great George St, Leeds LS1 3EX, United Kingdom. 2. Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, LIGHT Laboratories, Level 7, Leeds, LS2 9JT, United Kingdom. 3. Department of Radiology, Leeds General Infirmary, Leeds Teaching Hospital NHS Trust, Great George St, Leeds LS1 3EX, United Kingdom.
Abstract
OBJECTIVES: Standardised comparison of abdominal muscle and adipose tissue is often utilised in morphometric clinical research. Whilst measurements are traditionally standardised against the patient's height, this may not be always practically feasible. The aim of this study was to investigate the relationship between measurements of the vertebral body and patient height. METHODS: We analysed cross-sectional CT scans. Measurements of the vertebral body area (VBA), anteroposterior vertebral body diameter (APVBD) and lateral vertebral body diameter (LVBD) were made by two independent investigators by manual tracing. Patients were randomly divided into two groups: Group 1 standardisation and Group 2 validation. We compared height and vertebral body parameters from patients in Group 1 and mathematically modelled this relationship. We then utilised the model to predict the height of patients in Group 2 and compared this with their actual height. Observer variability was assessed using Bland-Altman plots and t-tests of differences. RESULTS: CT scans from 382 patients were analysed. No significant intraobserver or interobserver differences were apparent when measuring vertebral body parameters. We describe models which enable the prediction of the patients' height using the measured VBA, APVBD and LVBD. No significant differences were observed between the patients predicted and actual heights in the validation group. CONCLUSIONS: We demonstrate an important relationship between measurements of the patient's height and the vertebral body. This can be utilised in future research when the patient's height has not been measured. ADVANCES IN KNOWLEDGE: In the absence of the patient's height, we demonstrate that two-dimensional vertebral body parameters may be reliably used to standardise morphometric measurements.
OBJECTIVES: Standardised comparison of abdominal muscle and adipose tissue is often utilised in morphometric clinical research. Whilst measurements are traditionally standardised against the patient's height, this may not be always practically feasible. The aim of this study was to investigate the relationship between measurements of the vertebral body and patient height. METHODS: We analysed cross-sectional CT scans. Measurements of the vertebral body area (VBA), anteroposterior vertebral body diameter (APVBD) and lateral vertebral body diameter (LVBD) were made by two independent investigators by manual tracing. Patients were randomly divided into two groups: Group 1 standardisation and Group 2 validation. We compared height and vertebral body parameters from patients in Group 1 and mathematically modelled this relationship. We then utilised the model to predict the height of patients in Group 2 and compared this with their actual height. Observer variability was assessed using Bland-Altman plots and t-tests of differences. RESULTS: CT scans from 382 patients were analysed. No significant intraobserver or interobserver differences were apparent when measuring vertebral body parameters. We describe models which enable the prediction of the patients' height using the measured VBA, APVBD and LVBD. No significant differences were observed between the patients predicted and actual heights in the validation group. CONCLUSIONS: We demonstrate an important relationship between measurements of the patient's height and the vertebral body. This can be utilised in future research when the patient's height has not been measured. ADVANCES IN KNOWLEDGE: In the absence of the patient's height, we demonstrate that two-dimensional vertebral body parameters may be reliably used to standardise morphometric measurements.
Authors: Mateus D Marques; Raul D Santos; Jose R Parga; Jose A Rocha-Filho; Luiz A Quaglia; Marcio H Miname; Luiz F Avila Journal: Atherosclerosis Date: 2009-10-29 Impact factor: 5.162
Authors: Barbara J Nicklas; Brenda W J H Penninx; Alice S Ryan; Dora M Berman; Nicole A Lynch; Karen E Dennis Journal: Diabetes Care Date: 2003-05 Impact factor: 19.112
Authors: Mohammed Abdul Waduud; Pratik Adusumilli; Michael Drozd; Marc A Bailey; Gary Cuthbert; Christopher Hammond; Julian A Scott Journal: Br J Radiol Date: 2019-04-09 Impact factor: 3.039